ӢQ:(2S,3R)-2-((((9H-Fluoren-9-yl)Methoxy)carbonyl)aMino)-3-acetoxybutanoicacidӢͬx~:(2S,3R)-2-((((9H-Fluoren-9-yl)Methoxy)carbonyl)aMino)-3-acetoxybutanoicacid
؛̖ | Ҏ(gu) | (sh) | r |
---|---|---|---|
Q-0098988 | 100mg |
1
|
ԃr |
Q-0098988 | 250mg |
1
|
ԃr |
Q-0098988 | 500mg |
1
|
ԃr |
Q-0098988 | 1g |
1
|
ԃr |
Q-0098988 | 5g |
1
|
ԃr |

O--N-[̼ʻ]-L-KQ
O--N-[̼ʻ]-L-K
Ӣ (2S,3R)-3-acetyloxy-2-(9H-fluoren-9-ylmethoxycarbonylamino)butanoic acid
O--N-[̼ʻ]-L-KW(xu)|(zh)
ʽ C21H21NO6
|(zh) 383.13700
PSA 105.42000
LogP 3.13430
;
B(ti)w/ĩ/Һ
a(chn)أ
rg1
棺
SңpgӹٷƼ˾

(sh)Ϣ | |
---|---|
^B(ti) | wĩ |
|(zh)ָ(bio) | 95%+ |
ܽl | ЙC(j)܄/ˮ |
CAS̖ | N/A |
N/A | |
l | -20ܹⱣ |
rg | 1 |
\ݔl | Ҝ2 |
a(chn)Sң | pgӹٷƼ˾ |
-
pgӹٷƼ˾ṩ Danoprevir;ITMN-191; R7227; RO5190591; RG7227CAS850876-88-9 ^N/A N/A Hʹ
-
pgӹٷƼ˾ṩ DalfopristinCAS112362-50-2 ^N/A N/A Hʹ
-
ӢQ:beta-PineneӢͬx~:6,6-dimethyl-2-methylene-bicyclo(3.1.1)heptan;B-PINENE;BICYCLO[3.1.1]HEPTANE,6,6-DIMETHYL-2-METHYLENE
-
ӢQ:(N-(3-TRIFLUOROMETHYL)BENZENESULFONYL)ALANINEӢͬx~:2-[3-(TRIFLUOROMETHYL)BENZENESULFONAMIDE]PROPIONICACID;2-[3-(Trifluoromethyl)benzenesulphonamido]propionicacid97%